
Jan 2, 2020 · Produced by Stephanie Kaiser, Pharm.D., BCPS West Palm Beach VA Medical Center December 2019
Sep 8, 2020 · A Clarification of Individual Components excellence.acforum.org Background: Despite a relatively simple tool for categorizing stroke risk in patients with atrial fibrillation, there still remains …
Goodbye CHADSVASc: Sex Complicates Stroke Risk Scoring in AF
Nov 14, 2024 · Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their latest guidelines, and can end up penalizing women.
Aspirin to Prevent Stroke in Nonvalvular Atrial Fibrillation - Page 4
Role of Aspirin in AF As mentioned previously, aspirin is currently recommended for patients with a CHADS2 score or CHA2DS2-VASc score of 0–1, with preference given to anticoagulation in ...
Aspirin to Prevent Stroke in Nonvalvular Atrial Fibrillation - Page 2
Aspirin in Stroke Prevention in Nonvalvular Atrial Fibrillation and Stable Vascular Disease An Era of New Anticoagulants
Device Detected Atrial High-Rate Episodes (AHRE)/Subclinical AF (SCAF): AHREs detected by cardiac implantable devices are associated with a lower risk of stroke than that of clinical AF therefore the …
May 24 2024 This Week in Cardiology - Medscape
May 24, 2024 · This analysis, which was simultaneously published in the Journal of the American College of Cardiology, assessed the difference in stroke/systemic embolism and major bleeding …
Jun 15, 2022 · Recommendations for how to manage drug interactions between Paxlovid and the various anticoagulants come from the Liverpool COVID-19 Drug-Drug Interaction website and …
Anticoagulation Forum
The Resource Center is a repository of clinical resources and tools, expertly curated all in one place. Hundreds of resources are organized by overarching headings from most broad guidance. Click here …
Jan 24 2025 This Week in Cardiology - Medscape
Jan 24, 2025 · Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discusses in this week’s podcast.